Investing in Life Sciences Technology

Our Story

Biospring Partners was founded in 2020 by Michelle Dipp, MD PhD and Jennifer Lum to invest in growth-stage life sciences technology companies. Biospring leverages its deep experience in the life sciences and technology industries to support B2B services, tools, and enterprise software companies that are driving innovation across the life sciences industry and beyond.

michelle dipp biospring partners

Michelle Dipp, MD PhD

Co-Founder & Managing Partner

Jennifer Lum Biospring Partners

Jennifer Lum

Co-Founder & Managing Partner

Drew Pearson Biospring Partners

Drew Pearson

Head of Portfolio Management

Headshot (1)_edited_edited_edited.jpg

Mia Hopper

Vice President

 

Portfolio Companies

Katie Burke Biospring Partners

Katie Burke

Operational Expert

Colin Raney Biospring Partners

Colin Raney

Operational Expert

Erin Dobson Biospring Partners

Erin Dobson

Operational Expert

John-Baldoni Biospring Partners

John Baldoni

Operational Expert

Peter B. Henry Biospring Partners

Peter B. Henry

Advisor

Lisa Detwiler Biospring Partners

Lisa Detwiler

Advisor

John Sexton Biospring Partners

John Sexton

Advisor

Sir John Bell Biospring Partners

Sir John Bell

Advisor

Maulik Majmudar Biospring Partners

Dr. Maulik Majmudar

Advisor

Bob Pozen Biospring Partners

Bob Pozen

Advisor

 

News

PathAI Announces Completion of $165 Million Financing

PathAI will deploy its new capital to accelerate product development while continuing to prioritize the improvement of patient outcomes with reliable AI-powered technology and meaningful collaboration with pharmaceutical and diagnostic partners.